PHARMACYTE BIOTECH, INC. — Balance Sheet Charts
12 snapshots of history · ending 2026-01-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↑+27.5% +$12M
$56M
Current Assets↑+22.0% +$4M
$21M
Cash & Equivalents↑+23.1% +$4M
$20M
ST Investments↓-0.1% -$381
$372K
Receivables
—
Inventory
—
Net PPE
—
Intangibles↑+0.0% +$0
$2M
Total Liabilities↑+360.3% +$13M
$16M
Current Liabilities↑+40.5% +$484K
$2M
Account Payables↑+147.5% +$715K
$1M
Long-Term Debt
—
Short-Term Debt
—
Stockholders Equity↓-5.3% -$2M
$38M
Retained Earnings↓-3.4% -$3M
$-100M
Total Debt Carrying Amount
—